GET IN TOUCH
GET IN TOUCH

Miphic

The world's first mitochondrial drug discovery and precision medicine platform
Miphic technology
OUR MISSION
Mitochondria produce 95% of our energy. However right now we ignore mitochondrial function in a clinical setting.

We want to make diagnostics of mitochondrial function easily accessible for everyone.

MITOCHONDRIAL FUNCTION QUALITY IS PARAMOUNT IN ALMOST EVERY ASPECT OF HUMAN LIFE.

Therapeutic targeting of mitochondria has a great potential in:

  • Cancer
  • Neurodegenerative disease
  • Diabetes
  • Aging
WHAT WE OFFER

We perform multiparametric mitochondrial screening within three main domains:

1
Metabolic
Drug Discovery
  • Screening of metabolic drug libraries
  • Identification of the most potent candidates
  • Investigation of the mechanism of action
  • Identification and optimization of synergistic drug combinations
2
Personalized
Medicine Choice
  • We screen a sample of patient’s cells and determine which metabolic drug will be the best-suited for this patient.
3
Fundamental
Research On Metabolism
  • We determine how mitochondrial function reacts to various metabolites, stress conditions, genetic mutations and more.
Special Request

Do you have a special mitochondrial screening request?

Send Us Message
Additional Services

We don’t stop after mitochondrial screening. Learn more about our additional services:

deep data analysis
TECHNOLOGY

We Use Imaging-Based Approach To Compare How Mitochondria React To Different Drugs, Metabolites, Stress Conditions And So On.

You Have A Free Choice Of What To Test!

Before Treatment
After Treatment

PLATFORM BENEFITS

01
HIGH THROUGHPUT

We can screen up to 96 conditions simultenously. Conditions can imply: different drugs, different metabolites, different concentrations, different patient samples, and so on

02
HIGH
SENSITIVITY

We can detect changes of even small metabolic stimuli (e.g. micromolar concentrations of fatty acids)

03
FULL CUSTOMIZATION

We help you to design screening that is specifically optimized to your goals – technical questions, balance of sensitivity and throughput, and more

04
LOW CELL NUMBER REQUIREMENT

Miphic uses imaging-based approach (it is not a bulk method), so we can work with a very low amount of cells.

LAST ARTICLES
February 26, 2025
Precision Medicine. The Future of Healthcare You Can’t Ignore

By: Ryan Ho   The Next Revolution in Healthcare Imagine a world where you can know, with certainty, that the treatment for your disease has a close to 100% chance of recovery for yourself. Now, snap back into reality and realize that it’s more real of a possibility than you think. That is precision medicine, […]

READ ARTICLE
February 17, 2025
The Beginner’s Guide to Mitochondria (from a Beginner)

By Ryan Ho Yes, we all know that mitochondria are indeed the powerhouses of the cell. High school biology doesn’t fail us completely, after all. On a serious note, why aren’t we paying more attention to a major contributor to how our bodies produce energy? Mitochondria play such an important role in the creation of […]

READ ARTICLE
Explore all
DATA ANALYSIS
MACHINE LEARNING
For large-scale screening projects, we offer an additional machine learning modelling:
  • Deep analysis of complex data
  • Drug sensitivity prediction models
  • Correlation between different metabolic parameters and drug sensitivity
  • Combination of mitochondrial screening with the complementary data (genetic profiles, medical records and so on)